Prévisions du marché des réactifs et équipements de transfection en Amérique du Sud et centrale jusqu’en 2030 – Analyse régionale – par produit (réactifs et instruments), méthode (méthodes virales, méthodes non virales et méthodes hybrides), application (recherche biomédicale, production de protéines et administration thérapeutique) et utilisateur final (universités et instituts de recherche et sociétés pharmaceutiques et biotechnologiques)
Le fardeau économique croissant du cancer alimente le marché des réactifs et des équipements de transfection en Amérique du Sud et en Amérique centrale
Selon l\'Organisation mondiale de la santé ( OMS), le cancer est l\'une des principales causes de décès dans le monde et a causé environ 10 millions de décès en 2020. Selon le Centre international de recherche sur le cancer, le fardeau mondial du cancer est susceptible d\'augmenter avec l\'ajout de 30,2 millions de personnes supplémentaires. cas d’ici 2040. Selon l’Organisation du cancer du sein, environ 5 à 10 % des cas de cancer du sein dans le monde sont héréditaires et sont causés par des gènes anormaux transmis de génération en génération. Selon l\'article « Mode de vie, risque génétique et incidence du cancer », publié dans l\'International Journal of Epidemiology en 2023, près de 33 % des cancers qui surviennent sont héréditaires et le risque de mutations génétiques est élevé dans la maladie. C’est pourquoi les gens optent pour le profilage génétique pour la détection précoce et le traitement personnalisé des cas de cancer héréditaire. BRCA1 et BRCA2 sont parfois appelés gènes suppresseurs de tumeurs. Les personnes qui héritent des variantes nocives de l’un de ces gènes courent un risque plus élevé de plusieurs cancers, notamment le cancer du sein et de l’ovaire, entre autres types. Ces personnes ont également tendance à développer un cancer à un âge plus jeune que les personnes qui ne présentent pas de variations dans lesdits gènes. Les études axées sur le traitement des acides nucléiques par les cellules cancéreuses aideront probablement à comprendre le métabolisme du cancer. L\'ADN est généralement conditionné dans une particule virale ou non virale pour être transféré dans la cellule à transfecter. Le transfert de gènes a été proposé comme nouvelle approche pour améliorer l\'efficacité des médicaments antitumoraux dans le traitement des cancers incurables ou métastatiques. Il a été rapporté que l’association de thérapie génique et de médicaments (thérapie similaire) renforce les effets antiprolifératifs des traitements classiques dans les cancers du poumon, colorectal, pancréatique, de la vessie et du sein, entre autres. Ainsi, le fardeau économique croissant du cancer renforce le marché des réactifs et des équipements de transfection en Amérique du Sud et en Amérique centrale.
Aperçu du marché des réactifs et équipements de transfection en Amérique du Sud et centrale. La région de l\'Amérique du Sud et centrale est segmentée en Brésil, Argentine et reste de l\'Amérique du Sud et centrale. Le Brésil détient plus de la moitié de la part régionale en 2022.
Le Brésil a réalisé des développements significatifs dans l\'industrie pharmaceutique en raison de ses politiques et réformes économiques favorables, d\'une solide emprise dans la production pharmaceutique nationale et de dépenses de santé élevées. . Selon l\'Administration du commerce international (ITA), le Brésil est le plus grand marché de soins de santé d\'Amérique latine et consacre 9,1 % de son PIB aux soins de santé. Les entreprises nationales dominent la production totale de produits pharmaceutiques dans le pays, permettant ainsi ses activités commerciales. Selon le Département américain du Commerce, les sociétés nationales représentent environ 80 % du nombre total de sociétés pharmaceutiques au Brésil. Ainsi, le paysage croissant de l’industrie pharmaceutique est l’un des principaux facteurs de croissance du marché des réactifs et équipements de transfection au Brésil.
De plus, l\'Argentine possède la plus grande industrie pharmaceutique d\'Amérique du Sud et d\'Amérique centrale, après le Brésil. La croissance du marché des réactifs et équipements de transfection dans le pays est largement tirée par d’importants efforts de recherche et développement et par la production nationale croissante de produits pharmaceutiques. La demande croissante de produits pharmaceutiques et biopharmaceutiques en raison des incertitudes croissantes concernant les conditions de santé, de l’environnement réglementaire de plus en plus puissant pour l’industrie pharmaceutique et de l’amélioration de la logistique des matières premières est susceptible de favoriser la croissance du marché des réactifs et équipements de transfection en Argentine au cours de la période de prévision. .
Chiffre d\'affaires et prévisions du marché des réactifs et équipements de transfection en Amérique du Sud et centrale jusqu\'en 2030 (millions de dollars américains)
Segmentation du marché des réactifs et équipements de transfection en Amérique du Sud et centrale
Le Sud et Le marché des réactifs et équipements de transfection en Amérique centrale est segmenté en fonction du produit, de la méthode, de l’application, de l’utilisateur final et du pays.
En fonction du produit, le marché des réactifs et des équipements de transfection en Amérique du Sud et en Amérique centrale est divisé en réactifs et instruments. Le segment des réactifs détenait une part plus importante en 2022.
En termes de méthode, le marché des réactifs et des équipements de transfection en Amérique du Sud et en Amérique centrale est segmenté en méthodes virales, méthodes non virales et méthodes hybrides. Le segment des méthodes non virales détenait la plus grande part en 2022. Le segment viral est sous-catégorisé en rétrovirus, adénovirus, virus adéno-associé et virus de l\'herpès. Le segment non viral est divisé en méthode physique/mécanique et méthode chimique. En outre, le segment des méthodes physiques/mécaniques est sous-catégorisé en électroporation, microinjection, méthode biolistique, méthode laser, magnétofection et sonoporation. En outre, le segment des méthodes chimiques est sous-catégorisé en liposomal/à haute teneur en lipides et non liposomal/à haute teneur en lipides.
Par application, le marché des réactifs et équipements de transfection en Amérique du Sud et en Amérique centrale est segmenté en recherche biomédicale, production de protéines et administration thérapeutique. Le segment de la recherche biomédicale détenait la plus grande part en 2022.
Sur la base de l\'utilisateur final, le marché des réactifs et des équipements de transfection en Amérique du Sud et en Amérique centrale est divisé en universités et instituts de recherche et sociétés pharmaceutiques et biotechnologiques. Le segment des universitaires et des instituts de recherche détenait une part plus importante en 2022.
En fonction des pays, le marché des réactifs et des équipements de transfection en Amérique du Sud et en Amérique centrale est classé entre le Brésil, l\'Argentine et le reste de l\'Amérique du Sud et de l\'Amérique centrale. Le Brésil a dominé le marché des réactifs et équipements de transfection en Amérique du Sud et en Amérique centrale en 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG et MaxCyte Inc comptent parmi les principales sociétés opérant sur le marché des réactifs et des équipements de transfection en Amérique du Sud et en Amérique centrale.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - South & Central America Market Analysis
5.1 South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 South & Central America Transfection Reagents and Equipment Market Forecast Analysis
6. South & Central America Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Transfection Reagents and Equipment Market -Country Analysis
10.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Brazil: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Brazil: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 Argentina: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 Argentina: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. South & Central America Transfection Reagents and Equipment Market Segmentation
Table 2. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. South & Central America Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. South & Central America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. South & Central America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. South & Central America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. South & Central America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in South & Central America transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.